Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).

scientific article published on 22 September 2014

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials). is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJCA.2014.07.011
P698PubMed publication ID25256896
P5875ResearchGate publication ID267749869

P50authorJean Robert DelperoQ59677704
Claudio BassiQ88448313
Patrick PessauxQ90122718
Bert A. BonsingQ114258885
Sophie GourgouQ123973736
Josep Tabernero CaturlaQ37387600
Manfred P LutzQ38643693
John P NeoptolemosQ39065464
Roberto LabiancaQ39950156
Pascal HammelQ42932125
Aurélien LatoucheQ47245405
Alain SauvanetQ56812361
Carine BelleraQ56957858
P2093author name stringJulien Taieb
Teresa Macarulla
Franck Bonnetain
Daniela Aust
Michel Ducreux
Paula Ghaneh
Laurence Collette
Aimery De Gramont
Jocelyn Gal
Thierry Conroy
Emmanuel Mitry
Bengt Glimelius
Karin Haustermans
Christos Dervenis
Simone Mathoulin-Pélissier
Valérie Jooste
David Malka
Thomas Aparicio
Benoist Chibaudel
François Lacaine
Alain Hendlisz
Emmanuel Chamorey
Geertjan van Tienhoven
Virginie Berger
Jean Luc Van Laethem
Muriel Mauer
Erich Gerber
Adelaide Dousseau
Laeticia Dahan
P433issue17
P304page(s)2983-2993
P577publication date2014-09-22
P1433published inEuropean Journal of CancerQ332260
P1476titleGuidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).
P478volume50